Germany
I’m driven by working with people to solve meaningful problems—connecting insights, perspectives, and capabilities to develop solutions that ultimately make a real difference for patients, customers, and organisations. Whether coaching individuals or leading enterprise‑level initiatives, my focus is on understanding the core challenges, shaping customer-centric solutions, and translating strategy into action. I’m most effective where clarity is needed—helping teams move from complexity to focus and momentum. I enjoy tackling complex organisational problems: drawing out insight from ambiguity, building clear and pragmatic strategies, and aligning teams behind shared objectives. This is where I add the most value—at the intersection of strategy, execution, and people. My career spans allied healthcare, human pharmaceuticals, and animal health. Across these settings, I’ve held a diverse range of roles that reflect both adaptability and a strong learning mindset. I thrive in environments that reward curiosity, cross‑functional collaboration, and sustained impact. Areas of expertise include: + Global commercial strategy + Market development + Brand strategy and pharmaceutical marketing + Customer experience strategy and design + Change management + Salesforce excellence + Coaching and people leadership
Global lead for Pulmonology disease area strategy. Responsible for development of indication level strategy, core Target Product Profiles and commercial viability for future indication areas. Global lead for commercial pipeline. Leading a team of pipeline marketing, market access, HEOR, pricing, and digital health experts to shape the long-term commercial strategy in Pulmonology. Global lead for Pulmonary Fibrosis Market Development. Leading the cross-functional team across Marketing, Market access, HEOR, Medical affairs, Patient engagement, Communications, Digital health, Partnerships, Public and government affairs, Customer insights, Healthcare affairs, and Scientific engagement to create a clear, impactful path across market development activities—ensuring that when new treatments reach patients, the healthcare ecosystem is ready to support them.
Led global marketing for Pulmonary Fibrosis portfolio. Responsible for OFEV, market expansion, and pre-launch market development for nerandomilast (PDE4Bi). I led a team of talented senior international product managers to deliver on global strategy and activities to develop the pulmonary fibrosis market, improve speed to diagnosis and ensure patients receive appropriate treatment. Our vision is to create a future without the threat of pulmonary fibrosis.
Led global Customer Experience strategy and transformation for Boehringer Ingelheim Animal Health. - Global CX strategy and prioritisation - CX design capabilities - CX change and transformation - Global/local governance - Learning excellence - Sales force effectiveness (SFE) - Activation & Account Planning (AAP)
Embracing the fusion of authenticity, trust, and customer loyalty